The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice
Open accessAbstract
Adiponectin has recently been shown to be a promising candidate for the treatment of obesity-associated metabolic syndromes. Replenishment of recombinant adiponectin in mice can decrease hyperglycemia, reverse insulin resistance, and cause sustained weight loss without affecting food intake. Here we report its potential roles in alcoholic and nonalcoholic fatty liver diseases in mice. Circulating concentrations of adiponectin decreased significantly following chronic consumption of high-fat ethanol-containing food. Delivery of recombinant adiponectin into these mice dramatically alleviated hepatomegaly and steatosis (fatty liver) and also significantly attenuated inflammation and the elevated levels of serum alanine aminotransferase. These therapeutic effects resulted partly from the ability of adiponectin to increase carnitine palmitoyltransferase I activity and enhance hepatic fatty acid oxidation, while it decreased the activities of two key enzymes involved in fatty acid synthesis, including acetyl-CoA carboxylase and fatty acid synthase. Furthermore, adiponectin treatment could suppress the hepatic production of TNF-α and plasma concentrations of this proinflammatory cytokine. Adiponectin was also effective in ameliorating hepatomegaly, steatosis, and alanine aminotransferase abnormality associated with nonalcoholic obese, ob/ob mice. These results demonstrate a novel mechanism of adiponectin action and suggest a potential clinical application of adiponectin and its agonists in the treatment of liver diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Adiponectin administration decreases IHTG (35), increases hepatic insulin sensitivity (36), and reverses obesity-related skeletal muscle insulin resistance (37).”
From Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity (2009) · cites this paper as [35]
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001) · Nature Medicine · doi:10.1038/90984 · Cited by 4,915
Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345
Plasma Concentrations of a Novel, Adipose-Specific Protein, Adiponectin, in Type 2 Diabetic Patients
Hotta, K., Funahashi, T., Arita, Y., Takahashi, M., Matsuda, M., Okamoto, Y., Iwahashi, H., Kuriyama, H., Ouchi, N., Maeda, K., et al. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.6.1595 · Cited by 3,133
The adipocyte-secreted protein Acrp30 enhances hepatic insulin action
Berg, A. H., Combs, T. P., Du, X., Brownlee, M., & Scherer, P. E. (2001) · Nature Medicine · doi:10.1038/90992 · Cited by 2,526
AdipoQ Is a Novel Adipose-specific Gene Dysregulated in Obesity
Hu, E., Liang, P., & Spiegelman, B. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.18.10697 · Cited by 2,261
Novel Modulator for Endothelial Adhesion Molecules
Ouchi, N., Kihara, S., Arita, Y., Maeda, K., Kuriyama, H., Okamoto, Y., Hotta, K., Nishida, M., Takahashi, M., Nakamura, T., et al. (1999) · Circulation · doi:10.1161/01.cir.100.25.2473 · Cited by 2,158
Diet-induced insulin resistance in mice lacking adiponectin/ACRP30
Maeda, N., Shimomura, I., Kishida, K., Nishizawa, H., Matsuda, M., Nagaretani, H., Furuyama, N., Kondo, H., Takahashi, M., Arita, Y., et al. (2002) · Nature Medicine · doi:10.1038/nm724 · Cited by 2,114
Fruebis, J., Tsao, T., Javorschi, S., Ebbets-Reed, D., Erickson, M., Yen, F. T., Bihain, B. E., & Lodish, H. F. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.2005 · Cited by 2,007
Cited by
Sorted by citations
Items 701–800 of 998
Xu, Y., Zhu, H., Li, W., Chen, D., Xu, Y., Xu, A., & Ye, D. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108284 · Cited by 31
Self-citationStudy of adiponectin in chronic liver disease and cholestasis
Salman, T., Allam, N. A. A., El-Azab, G., Shaarawy, A., Hassouna, M. M., & El-haddad, O. M. (2010) · Hepatology International · doi:10.1007/s12072-010-9216-0 · Cited by 30
Dohil, R., Meyer, L., Schmeltzer, S., Cabrera, B. L., Lavine, J. E., & Phillips, S. A. (2012) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2012.04.011 · Cited by 30
Church, S. J., Begley, P., Kureishy, N., McHarg, S., Bishop, P. N., Bechtold, D. A., Unwin, R. D., & Cooper, G. J. S. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.03.067 · Cited by 30
Self-citationHypoadiponectinemia and its Association with Liver Fibrosis in Morbidly Obese Patients
Nazal, L., Riquelme, A. J., Solı́s, N., Pizarro, M., Escalona, A., Burotto, M., Méndez, J. I., Saint-Jean, C., Concha, M. J., Giovanni, S., et al. (2010) · Obesity Surgery · doi:10.1007/s11695-009-0051-0 · Cited by 30
Relevance and consequence of chronic inflammation for obesity development
Rück, L., Wiegand, S., & Kühnen, P. (2023) · Molecular and Cellular Pediatrics · doi:10.1186/s40348-023-00170-6 · Cited by 35
Clinicopathological features of non‐alcoholic fatty liver disease
Sugimoto, K., & Takei, Y. (2011) · Hepatology Research · doi:10.1111/j.1872-034x.2011.00867.x · Cited by 29
A pilot trial of high-dose ursodeoxycholic acid in nonalcoholic steatohepatitis
Adams, L. A., Angulo, P., Petz, J., Keach, J. C., & Lindor, K. D. (2010) · Hepatology International · doi:10.1007/s12072-010-9195-1 · Cited by 29
Pecoraro, A., Nigro, E., Polito, R., Monaco, M. L., Scudiero, O., Mormile, I., Marcelli, A. C., Capasso, M., Habetswallner, F., Genovese, A., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00895 · Cited by 29
Macrophages as Key Players during Adipose Tissue–Liver Crosstalk in Nonalcoholic Fatty Liver Disease
Korf, H., Boesch, M., Meelberghs, L., & der Merwe, V. (2019) · Seminars in Liver Disease · doi:10.1055/s-0039-1687851 · Cited by 29
Bai, L., Kumar, S., Verma, S., & Seshadri, S. (2020) · 3 Biotech · doi:10.1007/s13205-020-02317-y · Cited by 29
Gopal, T., Ai, W., Casey, C. A., Donohue, T. M., & Saraswathi, V. (2021) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14698 · Cited by 30
AAV-mediated BMP7 gene therapy counteracts insulin resistance and obesity
Casana, E., Jiménez, V., Jambrina, C., Sacristan, V., MUÑOZ, S. A., Rodó, J., Grass, I., García, M., Mallol, C., León, X., et al. (2022) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2022.03.007 · Cited by 29
Yu, H., Li, S., Cao, M., Jiang, X., Feng, L., Zhao, J., & Gao, L. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.12 · Cited by 29
Harakawa, S., Inoue, N., Hori, T., Tochio, K., Kariya, T., Takahashi, K., Doge, F., MARTIN, D. E., Saito, A., Suzuki, H., et al. (2005) · Journal of Veterinary Medical Science · doi:10.1292/jvms.67.969 · Cited by 29
Kursawe, R., Narayan, D., Cali, A. M. G., Shaw, M. M., Pierpont, B. M., Shulman, G. I., & Caprio, S. (2010) · Obesity · doi:10.1038/oby.2010.23 · Cited by 29
Impaired adipogenic response to thiazolidinediones in mice expressing human apolipoproteinE4
Arbonés-Mainar, J. M., Johnson, L. A., Altenburg, M. K., Kim, H., & Maeda, N. (2010) · The FASEB Journal · doi:10.1096/fj.10-159517 · Cited by 29
The Effect of Onion Peel Extract on Inflammatory Mediators in Korean Overweight and Obese Women
Kim, K., & Yim, J. (2016) · Clinical Nutrition Research · doi:10.7762/cnr.2016.5.4.261 · Cited by 30
Kim, Y., Lee, S.-H., Park, S. G., Won, B. Y., Chun, H., Cho, D., Kim, M. J., Lee, J. E., Haam, J.-H., & Han, K. (2019) · Metabolism · doi:10.1016/j.metabol.2019.154026 · Cited by 29
Komori, T., Tanaka, M., Furuta, H., Akamizu, T., Miyajima, A., & Morikawa, Y. (2015) · Diabetologia · doi:10.1007/s00125-015-3613-9 · Cited by 29
Effects of DGAT1 deficiency on energy and glucose metabolism are independent of adiponectin
Streeper, R. S., Koliwad, S. K., Villanueva, C. J., & Farese, R. V. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00621.2005 · Cited by 29
Felder, T. K., Hahne, P., Soyal, S. M., Miller, K., Höffinger, H., Oberkofler, H., Krempler, F., & Patsch, W. (2010) · International Journal of Obesity · doi:10.1038/ijo.2010.7 · Cited by 29
Efdé, M., Houtman, P. M., Spoorenberg, J. P. L., & Jansen, T. (2005) · PubMed · Cited by 29
Effect of various factors on the induction of liver tumors in animals by quinoline.
Shinohara, Y., Ogiso, T., Hananouchi, M., Nakanishi, K., Yoshimura, T., & Ito, N. (1977) · PubMed · Cited by 29
Iacob, S. A., & Iacob, D. G. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.814209 · Cited by 27
Hashimoto, T., Igarashi, J., Hasan, A. U., Ohmori, K., Kohno, M., Nagai, Y., Yamashita, T., & Kosaka, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079724 · Cited by 27
Zhang, S., Wong, Y.-T., Tang, K.-Y., Kwan, H. Y., & Su, T. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.572729 · Cited by 28
Chang, G., Liu, H.-Y., Yang, W., Wang, C., Wu, C.-F., Lin, J.-W., Lin, W., Wang, Y.-C., Lin, T.-C., Liao, H.-J., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136680 · Cited by 29
Self-citationAdiponectin, May Be a Potential Protective Factor for Obesity-Related Osteoarthritis
Jiang, H., Pu, Y., Li, Z., Liu, W., Deng, Y., Liang, R., Zhang, X. M., & Zuo, H.-D. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s359330 · Cited by 28
Sim, M., Lee, H.-I., Ham, J. R., Seo, K., & Lee, M. (2015) · Journal of Functional Foods · doi:10.1016/j.jff.2015.03.014 · Cited by 28
Disease-Specific Mechanisms of Fibrosis: Hepatitis C Virus and Nonalcoholic Steatohepatitis
van der Poorten, D., & George, J. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.07.003 · Cited by 28
Melatonin alleviates alcoholic liver disease via EGFR–BRG1–TERT axis regulation
Che, Z., Song, Y., Xu, C., Li, W., Dong, Z., Wang, C., Ren, Y., So, K., Tipoe, G. L., Wang, F., et al. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.06.015 · Cited by 27
Nagao, K., Inoue, N., Inafuku, M., Shirouchi, B., Morooka, T., Nomura, S., Nagamori, N., & Yanagita, T. (2009) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.01.021 · Cited by 27
Zhou, M., Xu, A., Lam, K. S. L., Tam, P. K. H., Che, C., Chan, L., Lee, I., Wu, D., & Wang, Y. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.05.034 · Cited by 29
Self-citationKhan, M., Jahan, S., Khaliq, S., Ijaz, B., Ahmad, W., Samreen, B., & Hassan, S. (2010) · Archives of Virology · doi:10.1007/s00705-010-0797-7 · Cited by 27
Brunt, E. M., Neuschwander‐Tetri, B. A., & Burt, A. D. (2011) · Elsevier eBooks · doi:10.1016/b978-0-7020-3398-8.00006-4 · Cited by 27
An, S., Kim, G., Kim, H., Ahn, S., Kim, H., Ko, H., Hyun, Y. E., Nguyen, M., Jeong, J., Liu, Z., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01874 · Cited by 26
Patel, D. N., Sharma, D., & Mandal, P. (2022) · Mediators of Inflammation · doi:10.1155/2022/4230599 · Cited by 26
Toxicity of new emerging pollutant tris‐(2,3‐dibromopropyl) isocyanurate on BALB/c mice
Li, J., Zhang, X., Bao, J., Liu, Y., Li, J., Li, J., Liang, Y., Zhang, J., & Zhang, A. (2014) · Journal of Applied Toxicology · doi:10.1002/jat.3026 · Cited by 26
Dietary fiber improves lipid homeostasis and modulates adipocytokines in hamsters
Hung, S., Bartley, G. E., Young, S. A., Albers, D. R., Dielman, D., Anderson, W. H. K., & YOKOYAMA, W. H. (2009) · Journal of Diabetes · doi:10.1111/j.1753-0407.2009.00034.x · Cited by 26
Nishise, Y., Saito, T., Makino, N., Okumoto, K., Ito, J., Watanabe, H., Saito, K., Togashi, H., Ikeda, C., Kubota, I., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1862 · Cited by 26
The role of adiponectin in inflammatory gastrointestinal diseases
Schäffler, A., & Schölmerich, J. (2009) · Gut · doi:10.1136/gut.2008.159210 · Cited by 26
Chiu, Y., Chou, W.-L., Ko, M.-C., Liao, J.-C., & Huang, T. (2025) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2025.109920 · Cited by 26
Bueno, A. C., Sun, K., Martins, C. S., Elías, J., Miranda, W. R. D. H., Tao, C., Foss‐Freitas, M. C., Barbieri, M. A., Bettiol, H., de Castro, M., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3009 · Cited by 24
Qin, Y., & Tian, Y. (2010) · Journal of Translational Medicine · doi:10.1186/1479-5876-8-120 · Cited by 25
Li, Y., Zhang, S., Zhu, Z., Zhou, R., Xu, P., Zhou, L., Kan, Y., Li, J., Zhao, J., Fang, P., et al. (2021) · Journal of Ginseng Research · doi:10.1016/j.jgr.2021.10.005 · Cited by 25
Green tea extract increases adiponectin and PPAR α levels to improve hepatic steatosis
Marinovic, M. P., Filho, C. P. B. S., Batista, F. A. H., Avelino, T. M., Cogliati, B., Figueira, A. C. M., Otton, R., & Rodrigues, A. C. (2022) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2022.108957 · Cited by 25
Portillo-Sánchez, P., Yavuz, S., Bril, F., & Cusi, K. J. (2014) · Current Hepatology Reports · doi:10.1007/s11901-014-0229-3 · Cited by 25
Emerging drugs for non-alcoholic fatty liver disease
Federico, A., Niosi, M., Blanco, C. D. V., & Loguercio, C. (2008) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.13.1.145 · Cited by 25
Moriya, T., Naito, H., Ito, Y., & Nakajima, T. (2009) · Journal of Occupational Health · doi:10.1539/joh.k9001 · Cited by 25
Nonalcoholic fatty liver disease
Adams, L. A. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.1050114 · Cited by 25
Endocannabinoids and Their Role in Fatty Liver Disease
Mallat, A., & Lotersztajn, S. (2010) · Digestive Diseases · doi:10.1159/000282100 · Cited by 25
The genetics of nonalcoholic fatty liver disease
Österreicher, C. H., & Brenner, D. A. (2007) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31936-2 · Cited by 25
Adiponectin changes in HCV‐Genotype 4: relation to liver histology and response to treatment
Derbala, M. F. M., Rizk, N. M., Al-Kaabi, S., Amer, A., Shebl, F. M., Marri, A. A., Aigha, I. I., Alyaesi, D., Mohamed, H., Aman, H., et al. (2009) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2009.01096.x · Cited by 25
Is adiponectin level a predictor of nonalcoholic fatty liver disease in nondiabetic male patients?
Sargın, H. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i37.5874 · Cited by 25
Review: Non-alcoholic fatty liver disease: natural history, pathogenesis and treatment
McAvoy, N. C., Ferguson, J., Campbell, I. W., & Hayes, P. C. (2006) · The British Journal of Diabetes · doi:10.1177/14746514060060060201 · Cited by 26
do Nascimento, A. F., Ip, B. C., Luvizotto, R. A. M., Seitz, H. K., & Wang, X. (2013) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2304-3881.2013.07.05 · Cited by 24
Mechanisms of Simple Hepatic Steatosis
Matherly, S. C., & Puri, P. (2012) · Clinics in Liver Disease · doi:10.1016/j.cld.2012.05.005 · Cited by 25
Evaluation of standard liver volume formulae for Chinese adults
Shi, Z. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.4062 · Cited by 25
Casana, E., Jiménez, V., Sacristan, V., MUÑOZ, S. A., Jambrina, C., Rodó, J., García, M., Mallol, C., León, X., Franckhauser, S., et al. (2020) · International Journal of Obesity · doi:10.1038/s41366-020-00700-6 · Cited by 24
Fisher, L., Srikusalanukul, W., Fisher, A., & Smith, P. N. (2015) · International Journal of Medical Sciences · doi:10.7150/ijms.10696 · Cited by 24
Kasztelan‐Szczerbińska, B., Surdacka, A., Słomka, M., Roliński, J., Celiński, K., Smoleń, A., & Szczerbiński, M. (2013) · Mediators of Inflammation · doi:10.1155/2013/148526 · Cited by 24
Souza‐Smith, F. M., Siggins, R. W., & Molina, P. E. (2015) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12796 · Cited by 24
Elfeky, M., Kaede, R., Okamatsu‐Ogura, Y., & Kimura, K. (2016) · Mediators of Inflammation · doi:10.1155/2016/5701959 · Cited by 24
Adiponectin and its Hydrolase-Activated Receptors.
Sharma, A. X., & Holland, W. L. (2017) · PubMed · Cited by 24
He, L., Lu, X., & Chen, J. (2018) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2018.08.041 · Cited by 24
Visceral Obesity and Hypoadiponectinemia are Significant Determinants of Hepatic Dysfunction
Kamada, Y., Nakamura, T., Funahashi, T., Ryo, M., Nishizawa, H., Okauchi, Y., Fukushima, J., Yoshida, Y., Kiso, S., Shimomura, I., et al. (2009) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181962de8 · Cited by 24
Herbert, K. R., Williams, G. M., Cooper, G. J. S., & Brimble, M. A. (2011) · Organic & Biomolecular Chemistry · doi:10.1039/c1ob06394d · Cited by 26
Self-citationNonalcoholic Fatty Liver Disease
Sanyal, A. J. (2004) · Clinics in Liver Disease · doi:10.1016/j.cld.2004.04.014 · Cited by 53
Gallo, G., Nalli, G., Baratta, F., Desideri, G., & Savoia, C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26168081 · Cited by 27
The latest idea in NAFLD/NASH pathogenesis
Ono, M., Okamoto, N., & Saibara, T. (2010) · Clinical Journal of Gastroenterology · doi:10.1007/s12328-010-0182-9 · Cited by 23
Cholecystectomy as a risk factor for non-alcoholic fatty liver disease development
Rodríguez‐Antonio, I., López-Sánchez, G. N., Garrido-Camacho, V. Y., Uribe, M., Chávez-Tapia, N. C., & Nuño‐Lámbarri, N. (2020) · HPB · doi:10.1016/j.hpb.2020.07.011 · Cited by 23
Kim, K. J., Jeong, E.-S., Lee, K. H., Na, J.-R., Park, S., Kim, J. S., Na, C.-S., Kim, Y. R., & Kim, S. (2020) · Molecules · doi:10.3390/molecules25245954 · Cited by 23
Adiponectin-expressing Treg facilitate T lymphocyte development in thymic nurse cell complexes
Zhang, Y., Cao, H., Chen, J., Li, Y., Xu, A., & Wang, Y. (2021) · Communications Biology · doi:10.1038/s42003-021-01877-w · Cited by 24
Self-citationCalcium signalling in hepatic metabolism: Health and diseases
Humbert, A., Lefebvre, R., Nawrot, M., Caussy, C., & Rieusset, J. (2023) · Cell Calcium · doi:10.1016/j.ceca.2023.102780 · Cited by 28
Chen, C., Yang, W., Yang, H., Chen, C.-F., You, S., Wang, L., Lu, S., Liu, C., Kao, J., Chen, P., et al. (2014) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-0161 · Cited by 23
AMP-activated protein kinase and malonyl-CoA: Targets for treating insulin resistance?
Ye, J., Ruderman, N. B., & Kraegen, E. W. (2005) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2005.05.019 · Cited by 23
Honsawek, S., Chayanupatkul, M., Chongsrisawat, V., Theamboonlers, A., Praianantathavorn, K., Udomsinprasert, W., Vejchapipat, P., & Poovorawan, Y. (2011) · BMC Gastroenterology · doi:10.1186/1471-230x-11-16 · Cited by 23
Adipose tissue autophagy and homeostasis in alcohol-induced liver injury
Li, Y., & Ding, W. (2017) · Liver Research · doi:10.1016/j.livres.2017.03.004 · Cited by 23
Wang, H.-Y., Peng, H.-C., Chien, Y., Chen, Y.-L., Lu, N.-S., & Yang, S. (2018) · Nutrients · doi:10.3390/nu10070802 · Cited by 23
Sophocarpine alleviates non‐alcoholic steatohepatitis in rats
Song, C., Zeng, X. Y., Chen, S., Hu, P., Zheng, Z., Ning, B., Shi, J. G., Xie, W., & Chen, Y.-X. (2010) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2010.06561.x · Cited by 23
Anti-obesity Effect of HT048, a Herbal Combination, in High Fat Diet-Induced Obese Rats
Lim, D., Song, M., Park, J., Park, S. U., Kim, N., Gaire, B. P., Choi, H., & Kim, H. (2012) · Molecules · doi:10.3390/molecules171214765 · Cited by 23
Nutritional and Hormonal Modulation of Adiponectin and its Receptors adipoR1 and adipoR2
de Oliveira, C., de Mattos, A. B. M., Silva, C. B. R., Mota, J. F., & Zemdegs, J. C. S. (2012) · Vitamins and hormones · doi:10.1016/b978-0-12-398313-8.00003-8 · Cited by 23
Duan, F., Wu, J., Chang, J., Peng, H., Liu, Z., Liu, P., Han, X., Sun, T., Shang, D., Yang, Y., et al. (2024) · Differentiation · doi:10.1016/j.diff.2024.100832 · Cited by 27
Mohan, S. K., Veeraraghavan, V. P., & Jainu, M. (2015) · Europe PMC (PubMed Central) · Cited by 22
A synthetic free fatty acid-regulated transgene switch in mammalian cells and mice
Liu, Y., Hamri, G. C., Ye, H., & Fussenegger, M. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky805 · Cited by 23
Gao, S., Su, S., Zhang, E., Zhang, Y., Liu, J., Xie, S., Yue, W., Liu, R., & Yin, C. (2023) · Annals of Medicine · doi:10.1080/07853890.2023.2224046 · Cited by 25
Insights of mitochondrial involvement in alcoholic fatty liver disease
Nithyananthan, S. (2023) · Journal of Cellular Physiology · doi:10.1002/jcp.31100 · Cited by 23
Corrao, S., Calvo, L., Granà, W., Scibetta, S., Mirarchi, L., Amodeo, S., Falcone, F., & Argano, C. (2024) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2024.07.019 · Cited by 22
Yamamoto, H., Maeda, K., Uji, Y., Tsuchihashi, H., Mori, T., Shimizu, T., Endo, Y., Kadota, A., Miura, K., Koga, Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056129 · Cited by 22
Yang, Z. H., Wang, X., Wen, J., Ye, Z., Li, Q., He, M., Lu, B., Ling, C., Wu, S.-H., & Hu, R. (2011) · Archives of Medical Science · doi:10.5114/aoms.2011.24137 · Cited by 22
Flechtner‐Mors, M., George, S. N., Oeztuerk, S., Haenle, M. M., Köenig, W., Imhof, A., Boehm, B. O., Graeter, T., Mason, R. A., Kratzer, W., et al. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-207 · Cited by 22
Namvaran, F., Rahimi‐Moghaddam, P., Azarpira, N., & Dabbaghmanesh, M. H. (2011) · Molecular Biology Reports · doi:10.1007/s11033-011-1354-5 · Cited by 22
Shirpoor, A., Heshmati, E., Kheradmand, F., Gharalari, F. H., Chodari, L., Naderi, R., Majd, F. N., & Samadi, M. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.05.121 · Cited by 22
Jin, J., Peng, D., Yuan, S., Zhao, S., Ning, X.-H., Wang, S., & Li, S. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.07.031 · Cited by 22
Probable NAFLD, by ALT levels, and diabetes among Filipino-American Women
Wong, C. A., Araneta, M. R. G., Barrett-Connor, E. L., Alcaraz, J. E., Castañeda, D. M., & Macera, C. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.07.012 · Cited by 22
Review article: the pathogenesis of fibrosis in non‐alcoholic steatohepatitis
Marra, F., Aleffi, S., Bertolani, C., Petrai, I., & Vizzutti, F. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02595.x · Cited by 22
Priyadarsini, S., Moumita, S., Sahu, S., Jayabalan, R., & Mishra, M. (2019) · Invertebrate Neuroscience · doi:10.1007/s10158-019-0233-y · Cited by 22
Nepal, S., Kim, M. J., Lee, E.-S., Kim, J., Choi, D., Sohn, D., Lee, S., Song, K., Kim, S., Jeong, G., et al. (2014) · Food and Chemical Toxicology · doi:10.1016/j.fct.2014.02.027 · Cited by 21
Does adiponectin benefit steatotic liver transplantation?
Elias-Miró, M., Massip‐Salcedo, M., Jiménez‐Castro, M. B., & Peralta, C. (2011) · Liver Transplantation · doi:10.1002/lt.22358 · Cited by 21
Metadata
- Authors
- Xu, A., Wang, Y., Keshaw, H., Xu, L. Y., Lam, K. S. L., & Cooper, G. J. S.
- Affiliations
- University of Auckland (NZ)
- University of Hong Kong (HK)
- Corresponding author
- Xu, Aimin
- Venue
- Journal of Clinical Investigation
- Published
- 2003-07-01
- Volume
- 112
- Issue
- 1
- Pages
- 91-100
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC162288
- OpenAlex
- W2120590109
- Cited by
- 1,298
- References
- 68
- Citations by year
- 2026: 12 · 2025: 15 · 2024: 29 · 2023: 34 · 2022: 34 · 2021: 43 · 2020: 38 · 2019: 35 · 2018: 54 · 2017: 50 · 2016: 50 · 2015: 69 · 2014: 75 · 2013: 59 · 2012: 68
- FWCI
- 49.81
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- The HKU Scholars Hub (University of Hong Kong) (submittedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Funders
- Auckland Medical Research Foundation
- University of Hong Kong
- Health Research Council of New Zealand
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Keywords
- adiponectin, alcoholic fatty liver, non-alcoholic fatty liver disease, hepatic steatosis, hepatomegaly, liver inflammation, TNF-α, carnitine palmitoyltransferase 1, hepatic fatty acid oxidation, fatty acid synthesis, acetyl-CoA carboxylase, fatty acid synthase, alanine aminotransferase, ob/ob mice, obesity
- MeSH terms
- Alanine Transaminase, Animals, Fatty Acids, Fatty Liver, Fatty Liver, Alcoholic, Liver, Male, Mice, Inbred C57BL, Obesity, Morbid, Oxidation-Reduction, Proteins, Recombinant Proteins, Tumor Necrosis Factor-alpha, Intercellular Signaling Peptides and Proteins, Mice, Adiponectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review